Patients n | Death | p-value# | |||
TB-related | Overall | TB-related | Overall | ||
Total | 299 | 85 (28.4) | 99 (33.1) | ||
Treatment group | 0.009 | 0.004 | |||
1 | 61 | 15 (25.0) | 19 (31.2) | ||
2 | 133 | 44 (38.9) | 50 (44.3) | ||
3 | 125 | 26 (20.8) | 30 (24.0) | ||
Sex | 0.09 | 0.03 | |||
Female | 84 | 18 (21.4) | 20 (23.8) | ||
Male | 215 | 67 (31.2) | 79 (36.7) | ||
Age group yrs | <0.001 | <0.001 | |||
≤44 | 133 | 23 (17.3) | 26 (19.6) | ||
≥45 | 166 | 62 (37.4) | 73 (44.0) | ||
Type of MDR-TB | 0.02 | 0.02 | |||
Primary | 32 | 3 (9.4) | 4 (12.5) | ||
Acquired | 267 | 82 (30.7) | 95 (35.6) | ||
Smear | 0.09 | 0.08 | |||
Positive | 233 | 74 (31.8) | 86 (36.9) | ||
Negative | 31 | 4 (12.9) | 6 (19.4) | ||
Not done | 35 | 7 (20.0) | 7 (20.0) | ||
Number of drugs isolates were resistant to | 0.24 | 0.43 | |||
2 | 93 | 20 (21.5) | 25 (26.9) | ||
3 | 107 | 30 (28.0) | 36 (33.6) | ||
≥4 | 99 | 35 (35.4) | 38 (38.4) | ||
Number of drugs unused before | 0.50 | 0.31 | |||
0–2 | 92 | 27 (29.4) | 33 (35.9) | ||
≥3 | 207 | 59 (28.0) | 66 (31.9) | ||
Number of effective drugs used | 0.02 | 0.04 | |||
0–1 | 33 | 14 (42.4) | 15 (44.5) | ||
2–6 | 266 | 71 (26.7) | 84 (31.6) |
Data are expressed as n or n (%). #: p-value calculated with Kaplan–Meier analysis with long-rank test.